Reversal Agents - Neostigmine Flashcards

1
Q

What is the recommended dose range for Neostigmine? (Select all that apply)
a) 50-70 mcg/kg IV
b) Up to 80 mcg/kg IV
c) 5 mg IV as a maximum dose
d) 10 mg IV

A

a) 50-70 mcg/kg IV,
c) 5 mg IV as a maximum dose

Dose Range: 50-70 mcg/kg to max 5 mg (ceiling effect at 80 mcg/kg and will not work in deep NM block) or 5mg Neo with 1 mg Glyco

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the concentration of Neostigmine in a vial? (Select all that apply)
a) 1 mg/mL
b) 5 mg/mL
c) 10 mg/mL
d) 0.5 mg/mL

A

a) 1 mg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the onset time for Neostigmine? (Select all that apply)
a) 1-2 minutes
b) 5-10 minutes
c) 15-20 minutes
d) 30 minutes

A

b) 5-10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following describes the mechanism of action (MOA) of Neostigmine? (Select all that apply)
a) Acetylcholinesterase inhibitor
b) Cholinergic agent
c) Competitive antagonist
d) Depolarizing agent

A

a) Acetylcholinesterase inhibitor,
b) Cholinergic agent,
c) Competitive antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is Neostigmine metabolized and what are the characteristics of its metabolites? (Select all that apply)
a) 25-50% of Neostigmine is metabolized hepatically.
b) Neostigmine is metabolized to an active metabolite that is as potent as the parent drug.
c) The active metabolite is approximately 1/10 as potent as Neostigmine.
d) The majority of Neostigmine is eliminated unchanged in the urine.

A

a) 25-50% of Neostigmine is metabolized hepatically,

c) The active metabolite is approximately 1/10 as potent as Neostigmine,

d) The majority of Neostigmine is eliminated unchanged in the urine

Elimination: METAB: 25-50% hepatic. active metabolite (1/10 as potent) ELIM: 50-75% renal, unchanged. Prolonged severe renal fail (OK with prolonged NMB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What should be noted about the effectiveness of Neostigmine in deep neuromuscular block? (Select all that apply)
a) Neostigmine is effective in reversing deep neuromuscular block at doses above 80 mcg/kg.
b) Neostigmine will not be effective in deep neuromuscular block if the dose exceeds 80 mcg/kg.
c) A ceiling effect occurs at 80 mcg/kg, beyond which Neostigmine does not provide additional benefit.
d) Neostigmine can reverse any depth of neuromuscular block if used at a high enough dose.

A

b) Neostigmine will not be effective in deep neuromuscular block if the dose exceeds 80 mcg/kg,

c) A ceiling effect occurs at 80 mcg/kg, beyond which Neostigmine does not provide additional benefit

Dose Range: 50-70 mcg/kg to max 5 mg (ceiling effect at 80 mcg/kg and will not work in deep NM block) or 5mg Neo with 1 mg Glyco

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the approximate half-life of Neostigmine? (Select all that apply)
a) 30 minutes
b) 60 minutes
c) 90 minutes
d) 120 minutes

A

Answer: b) 60 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following are muscarinic cholinergic effects associated with Neostigmine? (Select all that apply)

a) Miosis
b) Urination
c) Diarrhea
d) Diaphoresis
e) Lacrimation
f) Excitation (CNS)
g) Salivation

A

a) Miosis,
b) Urination,
c) Diarrhea,
d) Diaphoresis,
e) Lacrimation,
f) Excitation (CNS),
g) Salivation

MUSCARINIC CHOLINERGIC effects: MUDDLES

Pre-treat with anticholinergic Glycopyrrolate (antimuscarinic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In which patient population is Neostigmine particularly prioritized for use? (Select all that apply)
a) Renal patients
b) Hepatic patients
c) Patients with normal renal function
d) Patients with cardiovascular diseases

A

a) Renal patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the primary classification of Neostigmine? (Select all that apply)
a) Carbamate
b) Quaternary amine
c) Benzylisoquinolinium
d) Depolarizing agent

A

a) Carbamate
b) Quaternary amine

Action: Carbamate (quaternary amine) NMBD Reversal agent; priority used when renal pt; allows increased ACh at NMJ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is have preferably 2 twitches important before administering Neostigmine for neuromuscular blockade reversal? (Select all that apply)

a) To ensure that Neostigmine can effectively reverse the blockade at multiple neuromuscular junction sites.
b) To confirm that the neuromuscular blockade is completely resolved.
c) To avoid recurarization, which can occur if the blockade is too deep and only a few receptor sites are available.
d) To ensure that the patient is fully conscious before administering the reversal agent.

A

a) To ensure that Neostigmine can effectively reverse the blockade at multiple neuromuscular junction sites,

c) To avoid recurarization, which can occur if the blockade is too deep and only a few receptor sites are available

If you have 0/4, you will just be competitively reversing the few sites available and will have recurarization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the minimum number of twitches required to effectively use Neostigmine for reversing neuromuscular blockade? (Select all that apply)
a) 0 twitches
b) 1-2 twitches
c) 3 twitches
d) 4 twitches

A

b) 1-2 twitches

When to use: You MUST have 1-2 twitches, preferably 2, in order to successfully reverse the patient. If you have 0/4, you will just be competitively reversing the few sites available and will have recurarization.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What precautions should be taken when using Neostigmine in elderly patients? (Select all that apply)

a) Neostigmine’s duration of action may be prolonged in elderly patients.
b) Elderly patients typically require higher doses of Neostigmine.
c) Monitor for potential recurarization due to prolonged neuromuscular blockade.
d) There is no need for dose adjustment in elderly patients.

A

a) Neostigmine’s duration of action may be prolonged in elderly patients,

c) Monitor for potential recurarization due to prolonged neuromuscular blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a key characteristic of Neostigmine regarding its interaction with the blood-brain barrier (BBB)? (Select all that apply)

a) Neostigmine passes through the BBB.
b) Neostigmine does not pass through the BBB.
c) Neostigmine can cause central nervous system effects despite not crossing the BBB.

A

b) Neostigmine does not pass through the BBB

Pre-treat with anticholinergic Glycopyrrolate (antimuscarinic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What side effects from Neostigmine? (Select all that apply)

a) NAUSEA
b) Increased secretions = Laryngospasm
c) Bradycardia
d) Asystole
e) Hypertension

A

a) Nausea
b) Increased secretions = Laryngospasm
c) Bradycardia
d) Asystole

Pre-treat with anticholinergic Glycopyrrolate (antimuscarinic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
14
Q
A
15
Q
A
16
Q
A
17
Q
A
18
Q
A